N E W S B Y T E S
Bharat Biotech and Bilthoven Biologicals collaborate to produce & supply oral polio vaccines
Bharat Biotech and Bilthoven Biologicals B . V ., ( BBio ), a wholly owned subsidiary of Serum Institute of India Private Limited , based in Netherlands , have collaborated to further strengthen the production and supply security of Oral Polio Vaccines ( OPV ). A requisite agreement has been signed between BBIL and BBio wherein BBIL will procure drug substances for the production of oral polio vaccines to be supplied within India and globally .
Through this collaboration , BBIL and BBio will jointly obtain the regulatory approvals and licenses required to commercially manufacture OPVs in India for global supplies from drug substances manufactured in the Netherlands at Bilthoven Biologicals . As India approaches the critical phase of global polio eradication , this collaboration will support the effort to create a polio-free world .
Leveraging 3D bioprinting to develop tailored regenerative therapies for knee meniscus tears
Researchers from the Indian Institute of Technology Guwahati in collaboration with the University of Animal and Fishery Sciences , Kolkata have formulated three ingenious treatment solutions for a certain type of knee injury that has historically proven difficult to treat . By developing these key regenerative therapies , the researchers have provided possible alternative solutions to manage the problem of a knee meniscus tear , an injury to tissue in one ’ s knee joints .
Trauma to the knee meniscus , a cushioning tissue in the knee joint , is a commonly occurring yet complex problem . It can be caused during dayto-day activities by sudden accidents , mishaps while playing sports , or simply aging . A tear in this crucial tissue can make it difficult for an individual to walk , run or participate in daily activities . However , these new developments signal a significant advancement in treating knee injuries , providing a solution that is custommade for each patient and could also potentially prevent future complications such as osteoarthritis .
10
BioVoiceNews | May / June 2024